Lippa Arnold 4
4 · RespireRx Pharmaceuticals Inc. · Filed Sep 14, 2018
Insider Transaction Report
Form 4
Lippa Arnold
DirectorChairman, CEO and PresidentOther
Transactions
- Purchase
Common Stock
2018-09-12+47,620→ 47,620 total - Gift
Common stock
2018-09-12−47,620→ 0 total - Gift
Common stock Warrants (right to buy)
2018-09-12−47,620→ 0 totalExercise: $1.57From: 2018-09-12Exp: 2023-04-30→ Common Stock (47,620 underlying) - Purchase
Common Stock Warrants (right to buy)
2018-09-12+47,620→ 47,620 totalExercise: $1.57From: 2018-09-12Exp: 2023-04-30→ Common Stock (47,620 underlying)
Footnotes (2)
- [F1]On April 5, 2018, the Company issued a promissory note to Dr. Lippa in the principal amount of $50,000. On September 12, 2018, the Company redeemed the note, and Dr. Lippa used $50,000 in redemption proceeds to acquire 47,620 units, each unit comprising 47,620 shares of Common Stock and 47,620 Warrants, each Warrant representing the right to purchase an additional share of Common Stock.
- [F2]Dr. Lippa gifted these securities into a family trust for estate planning purposes. He is not the trustee and does not exercise voting control over shares held in the trust but he is a beneficiary of the trust.